NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response

News   Nov 28, 2014

 
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
 
 
 

RELATED ARTICLES

Synthetic Horsepox Virus Could Lead to More Effective Smallpox Vaccine

News

University of Alberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox.

READ MORE

Radical New Approach to Vaccine Development Could Help Reduce Illness From Flu

News

More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help lower that figure for future flu seasons.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE